Skip to main content
. 2016;17(10):4735–4739. doi: 10.22034/APJCP.2016.17.10.4735

Table 1.

Characteristics of 50 Patients and Univariate Analyses for Recurrence-Free Survival

Variable No. of patients (%) Median RFS, day. 1 yrs. RFS (%) P value
Age (yrs.) 0.568
 <60 31 (62.0%) 153 13.8%
 >60 19 (38.0%) 201 19.5%
Gender 0.244
 Male 26 (52.0%) 195 11.2%
 Female 24 (48.0%) 188 20.9%
Tumor number 0.268
 Solitary 43 (86.0%) 170 13.0%
 Multiple 7 (14.0%) 235 33.3%
T Staging 0.895
 T1 11 (22.0%) 153 27.3%
 T2 9 (18.0%) 231 29.6%
 T3 30 (60.0%) 195 5.1%
 T4 0 - -
N Staging 0.419
 N0 18 (36.0%) 195 19.2%
 N1 32 (64.0%) 170 14.1%
AJCC 7th Staging 0.19
 1 3 (6.0%) 575 66.7%
 2 3 (6.0%) 112 0.0%
 3 12 (24.0%) 195 10.4%
 4 32 (64.0%) 170 14.1%
Tumor grade 0.796
 Well diff. 24 (48.0%) 127 11.2%
 Mod diff. 7 (14.0%) 195 0.0%
 Poor diff. 5 (10.0%) 318 0.0%
 Not specified 14 (28.0%) 205 31.4%
Type of liver resection 0.295
 Right sided hepatectomy 39 (78.0%) 170 10.4%
 Left sided hepatectomy 11 (22.0%) 195 35.8%
Surgical margin status 0.127
 Free 23 (46.0%) 205 26.7%
 Not free 27 (54.0%) 133 4.9%
Postoperative chemotherapy 0.137
 Yes 18 (32.0%) 219 20.6%
 No 32 (64.0%) 127 13.5%